Breaking news coverage from cryptocurrency world about key figures, exchanges, startups, investment, applications, regulation and more.
As the volatility spikes by the day, Bitcoin’s average transaction fees have scaled to their highest since 2018, around $13.82.
The move from Bakkt further complements the decision of Coinbase and other exchanges including Binance US, OKCoin which had removed XRP coin from their platforms.
The move by Bilibili to file for a secondary listing in Hong Kong is a clear manifestation of the tension between the United States and the Republic of China.
Although Snap did not disclose the financial side, it is expected that StreetCred will shut down its platform as part of the acquisition deal.
Despite the reported drop in the shares of Pinduoduo, the company is still seeing potential growth in other key aspects of its metrics.
Bakkt projects an all-round growth with a 75% surge in revenue by 2025. This means the value will be around $515 billion with a cash-flow positive expected to take effect in 2023.
This past year has been a huge test for financial platforms.
The shares of Nio are bound to see bigger moves particularly with the firm’s readiness to throw its gauntlet in churning out advanced technologies.
As the asset retested its all-time high, Ethereum traders and investors are eagerly awaiting the launch of CME’s Eth futures scheduled in four weeks.
TSLA stock price corrected as markets remained under pressure on Monday. However, Bofa Securities analyst still remains bullish on TSLA stock saying that it can enter an upward spiral anytime soon.
In a SPAC merger with Victory Park Capital, Bakkt plans to go public on the New York Stock Exchange (NYSE) at an estimated valuation of $2.1 billion. Bakkt parent ICE has pledged a $50 million initial investment.
While the proliferation of crypto mining firms is gradually taking the center stage, the duo of Riot Blockchain and Marathon Patent Group currently dominates the sphere and are backed up by investors’ money.
With a market capitalization of nearly $36 billion, Ford is up 0.11% over the past year. The company has jumped 5.80% in its year-to-date record.
The next step will be a trial with 500 patients included. Eli Lilly and Co is planning to replicate the results and continue to research the drug’s effectiveness.
Despite the current performance of Tesla, analysts, including those bullish on the stock, are projecting a moderate price target.